BullFrog AI Holdings (BFRG) Net Shares Issued and Repurchased (2021 - 2025)
BullFrog AI Holdings' (BFRG) quarterly Net Shares Issued and Repurchased came in at $360446.0 in Q4 2025, down 8.05% on a YoY basis from $392000.0 in Q4 2024, and up 5.38% quarter-over-quarter from $342030.0 in Q3 2025.
Analysis
BullFrog AI Holdings (BFRG) Net Shares Issued and Repurchased (2021 - 2025) Analysis & Trends
BullFrog AI Holdings (BFRG) has reported Net Shares Issued and Repurchased for 5 consecutive years, with $360446.0 the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Net Shares Issued and Repurchased fell 8.05% year-over-year to $360446.0; the trailing twelve-month figure through Dec 2025 stood at $360446.0 (down 8.05% YoY), and the FY2025 full-year result was $360446.0, down 8.05% from the prior year.
- Net Shares Issued and Repurchased advanced to $360446.0 in Q4 2025 per BFRG's latest filing, from $342030.0 in the prior quarter.
- Across five years, Net Shares Issued and Repurchased topped out at $458500.0 in Q4 2023 and bottomed at $184500.0 in Q1 2023.
- Historically, Net Shares Issued and Repurchased has averaged $349222.0 across 5 years, with a median of $376223.0 in 2024.
- The sharpest annual moves came in 2023 and 2024: Net Shares Issued and Repurchased plunged 53.8% in 2023, then jumped 62.06% in 2024.
- Over 5 years, Net Shares Issued and Repurchased stood at $445536.0 in 2021, then slipped by 10.37% to $399354.0 in 2022, then increased by 14.81% to $458500.0 in 2023, then decreased by 14.5% to $392000.0 in 2024, then decreased by 8.05% to $360446.0 in 2025.
- According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $360446.0, $342030.0, and $211500.0 for Q4 2025, Q3 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | - |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | - |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | - |
| 10 | BullFrog AI Holdings | 9.27 Mn | 2.35 Mn | 106,899.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 360,446.00 |
| Sep 30, 2025 | 342,030.00 |
| Mar 31, 2025 | 211,500.00 |
| Dec 31, 2024 | 392,000.00 |
| Mar 31, 2024 | 299,000.00 |
| Dec 31, 2023 | 458,500.00 |
| Mar 31, 2023 | 184,500.00 |
| Dec 31, 2022 | 399,354.00 |
| Mar 31, 2022 | 399,354.00 |
| Dec 31, 2021 | 445,536.00 |